Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

44 results about "Excess weight" patented technology

Weight can affect a person's self-esteem. Excess weight is highly visible and evokes some powerful reactions, however unfairly, from other people and from the people who carry the excess weight.

Sensor Driven Gastric Stimulation for Patient Management

Gastric stimulation systems and methods are provided for treating a patient, particularly by modifying behavior of the patient leading to excess weight loss. In some embodiments, such weight loss is achieved with a combination approach which includes two or more of the following: acute screening of the potential patients, gastric stimulation, induction of symptoms or specific behaviors and integration of patient management data into the treatment plan. Gastric stimulation is provided to portions of the gastrointestinal tract, particularly the stomach, with the use of at least one electrode. A variety of gastric stimulation systems may be used, including stimulators that are endoscopically placed, laparoscopically placed or placed by modified or combination methods.
Owner:INTRAPACE

Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis

InactiveCN102811731APrevent or treat obesityPrevent or treat atherosclerosisPeptide/protein ingredientsMetabolism disorderSubtilisinIntestinal structure
The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The subject matter of the invention is also such a composition for use as a medicament, as a cosmetic agent, as a medical device, as a food composition, as a food supplement or else as a nutriceutical, in particular for use in preventing or treating obesity, atherosclerosis or type II diabetes, or else for use in preventing or reducing excess weight.
Owner:IMARKO RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products